Show simple item record

dc.contributor.authorIsaakidis, P
dc.contributor.authorDas, M
dc.contributor.authorKumar, A M V
dc.contributor.authorPeskett, C
dc.contributor.authorKhetarpal, M
dc.contributor.authorBamne, A
dc.contributor.authorAdsul, B
dc.contributor.authorManglani, M
dc.contributor.authorSachdeva, K S
dc.contributor.authorParmar, M
dc.contributor.authorKanchar, A
dc.contributor.authorRewari, B B
dc.contributor.authorDeshpande, A
dc.contributor.authorRodrigues, C
dc.contributor.authorShetty, A
dc.contributor.authorRebello, L
dc.contributor.authorSaranchuk, P
dc.date.accessioned2014-11-14T17:52:05Z
dc.date.available2014-11-14T17:52:05Z
dc.date.issued2014-10-21
dc.identifier.citationAlarming Levels of Drug-Resistant Tuberculosis in HIV-Infected Patients in Metropolitan Mumbai, India. 2014, 9 (10):e110461 PLoS ONEen_GB
dc.identifier.issn1932-6203
dc.identifier.pmid25333696
dc.identifier.doi10.1371/journal.pone.0110461
dc.identifier.urihttp://hdl.handle.net/10144/334903
dc.description.abstractDrug-resistant tuberculosis (DR-TB) is a looming threat to tuberculosis control in India. However, no countrywide prevalence data are available. The burden of DR-TB in HIV-co-infected patients is likewise unknown. Undiagnosed and untreated DR-TB among HIV-infected patients is a major cause of mortality and morbidity. We aimed to assess the prevalence of DR-TB (defined as resistance to any anti-TB drug) in patients attending public antiretroviral treatment (ART) centers in greater metropolitan Mumbai, India.
dc.language.isoenen
dc.publisherPublic Library of Scienceen_GB
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen_GB
dc.titleAlarming Levels of Drug-Resistant Tuberculosis in HIV-Infected Patients in Metropolitan Mumbai, Indiaen
dc.identifier.journalPloS Oneen_GB
refterms.dateFOA2019-03-04T11:31:34Z
html.description.abstractDrug-resistant tuberculosis (DR-TB) is a looming threat to tuberculosis control in India. However, no countrywide prevalence data are available. The burden of DR-TB in HIV-co-infected patients is likewise unknown. Undiagnosed and untreated DR-TB among HIV-infected patients is a major cause of mortality and morbidity. We aimed to assess the prevalence of DR-TB (defined as resistance to any anti-TB drug) in patients attending public antiretroviral treatment (ART) centers in greater metropolitan Mumbai, India.


Files in this item

Thumbnail
Name:
Isaakidis P et al - 2014 - ...
Size:
889.0Kb
Format:
PDF
Description:
Main article

This item appears in the following Collection(s)

Show simple item record